-
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
van Linde, M. E., Labots, M., Brahm, C. G., Hovinga, K. E., de Witt Hamer, P. C., Honeywell, R. J., de Goeij-de Haas, R., Henneman, A. A., Knol, J. C., Peters, G. J., Dekker, H., Piersma, S. R., Pham, T. V., Vandertop, W. P., Jiménez, C. R., Verheul, H. M. W. & van Linde, M. E., 15 Apr 2022, In: Clinical Cancer Research. 28, 8, p. 1595-1602 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo
Houweling, M., Abdul, U. K., Brahm, C., Lagerweij, T., Heukelom, S., Koken, P. W., Honeywell, R., Wedekind, L. E., Peters, G. J., Verheul, H., Sminia, P., Noske, D., Wurdinger, T. & Westerman, B. A., 2022, (E-pub ahead of print) In: Journal of Cancer Research and Clinical Oncology.Research output: Contribution to journal › Article › Academic › peer-review
-
Improving the standard of care in glioblastoma: novel diagnostic and therapeutic approaches
Brahm, C. G., 3 Jun 2021, s.l.: ProefschriftMaken || www.proefschriftmaken.nl. 171 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications